Newbridge Financial Services Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,300
Closed -$10.5K 1353
2023
Q1
$10.5K Sell
1,300
-3,000
-70% -$24.1K 0.01% 898
2022
Q4
$27K Sell
4,300
-3,150
-42% -$22K 0.02% 630
2022
Q3
$51K Sell
7,450
-1,000
-12% -$6.95K 0.03% 444
2022
Q2
$71K Hold
8,450
0.04% 327
2022
Q1
$193K Buy
8,450
+1,250
+17% +$30.6K 0.09% 203
2021
Q4
$199K Sell
7,200
-1,110
-13% -$29.7K 0.09% 205
2021
Q3
$231K Buy
8,310
+510
+7% +$14.5K 0.14% 157
2021
Q2
$229K Hold
7,800
0.14% 155
2021
Q1
$248K Sell
7,800
-1,200
-13% -$35.2K 0.18% 129
2020
Q4
$187K Sell
9,000
-6,140
-41% -$115K 0.15% 141
2020
Q3
$235K Buy
+15,140
New +$261K 0.23% 96

Other funds holding BHC

Newbridge Financial Services Group's BHC Position: Q2 2023 in Review

Newbridge Financial Services Group sold out of Bausch Health (BHC) in Q2 2023, closing a stake of 1,300 shares — an estimated $10.5K sold.

Newbridge Financial Services Group first reported a position in BHC in Q3 2020 and held it in 11 quarters. The position peaked at $248K in Q1 2021. 232 funds tracked by Wall St. Rank hold BHC as of Q2 2023.

  • Newbridge Financial Services Group reported no remaining Bausch Health position as of Q2 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 1,300 Bausch Health shares in Q2 2023, an estimated $10.5K.
  • Newbridge Financial Services Group first reported a position in Bausch Health in Q3 2020 and held it in 11 quarters.
  • Newbridge Financial Services Group's Bausch Health position peaked at $248K in Q1 2021.
  • 232 funds tracked by Wall St. Rank held Bausch Health as of Q2 2023.

Based on Newbridge Financial Services Group's 13F filing for Q2 2023, filed 21 Jul 2023.